annual CFF:
$17.70M-$318.90M(-94.74%)Summary
- As of today (May 29, 2025), MIRM annual cash flow from financing activities is $17.70 million, with the most recent change of -$318.90 million (-94.74%) on December 31, 2024.
- During the last 3 years, MIRM annual CFF has fallen by -$55.77 million (-75.91%).
- MIRM annual CFF is now -94.74% below its all-time high of $336.60 million, reached on December 31, 2023.
Performance
MIRM Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$6.36M+$1.02M(+19.08%)Summary
- As of today (May 29, 2025), MIRM quarterly cash flow from financing activities is $6.36 million, with the most recent change of +$1.02 million (+19.08%) on March 31, 2025.
- Over the past year, MIRM quarterly CFF has increased by +$5.15 million (+427.72%).
- MIRM quarterly CFF is now -96.93% below its all-time high of $207.13 million, reached on September 30, 2023.
Performance
MIRM quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$22.85M+$5.15M(+29.12%)Summary
- As of today (May 29, 2025), MIRM TTM cash flow from financing activities is $22.85 million, with the most recent change of +$5.15 million (+29.12%) on March 31, 2025.
- Over the past year, MIRM TTM CFF has dropped by -$301.96 million (-92.96%).
- MIRM TTM CFF is now -93.21% below its all-time high of $336.60 million, reached on December 31, 2023.
Performance
MIRM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
MIRM Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -94.7% | +427.7% | -93.0% |
| 3 y3 years | -75.9% | -64.9% | -73.1% |
| 5 y5 years | -86.1% | -85.8% | -86.7% |
MIRM Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -94.7% | at low | -96.9% | +2032.8% | -93.2% | +61.7% |
| 5 y | 5-year | -94.7% | at low | -96.9% | +2032.8% | -93.2% | +61.7% |
| alltime | all time | -94.7% | at low | -96.9% | +2032.8% | -93.2% | >+9999.0% |
MIRM Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $6.36M(+19.1%) | $22.85M(+29.1%) |
| Dec 2024 | $17.70M(-94.7%) | $5.34M(+38.2%) | $17.70M(+25.2%) |
| Sep 2024 | - | $3.86M(-47.0%) | $14.14M(-93.5%) |
| Jun 2024 | - | $7.29M(+505.1%) | $217.40M(-33.1%) |
| Mar 2024 | - | $1.21M(-32.2%) | $324.82M(-3.5%) |
| Dec 2023 | $336.60M(+208.6%) | $1.78M(-99.1%) | $336.60M(+0.6%) |
| Sep 2023 | - | $207.13M(+80.6%) | $334.49M(+56.7%) |
| Jun 2023 | - | $114.71M(+783.2%) | $213.43M(+105.3%) |
| Mar 2023 | - | $12.99M(-4047.4%) | $103.97M(-4.7%) |
| Dec 2022 | $109.09M | -$329.00K(-100.4%) | $109.09M(-0.9%) |
| Sep 2022 | - | $86.07M(+1540.6%) | $110.03M(+352.6%) |
| Jun 2022 | - | $5.25M(-71.0%) | $24.31M(-71.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $18.10M(+2843.7%) | $84.98M(+15.7%) |
| Dec 2021 | $73.47M(-59.5%) | $615.00K(+78.3%) | $73.47M(-64.6%) |
| Sep 2021 | - | $345.00K(-99.5%) | $207.36M(-0.8%) |
| Jun 2021 | - | $65.91M(+899.6%) | $209.11M(+46.0%) |
| Mar 2021 | - | $6.59M(-95.1%) | $143.22M(-21.0%) |
| Dec 2020 | $181.29M(+42.5%) | $134.51M(+6317.4%) | $181.29M(+287.5%) |
| Sep 2020 | - | $2.10M(+8284.0%) | $46.78M(-58.6%) |
| Jun 2020 | - | $25.00K(-99.9%) | $113.10M(-34.2%) |
| Mar 2020 | - | $44.66M(>+9900.0%) | $171.84M(+35.1%) |
| Dec 2019 | $127.18M | $0.00(-100.0%) | $127.18M(0.0%) |
| Sep 2019 | - | $68.42M(+16.4%) | $127.18M(+116.4%) |
| Jun 2019 | - | $58.76M(>+9900.0%) | $58.76M(>+9900.0%) |
| Mar 2019 | - | $0.00 | $0.00 |
FAQ
- What is Mirum Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals annual CFF year-on-year change?
- What is Mirum Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals quarterly CFF year-on-year change?
- What is Mirum Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals TTM CFF year-on-year change?
What is Mirum Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of MIRM is $17.70M
What is the all time high annual CFF for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high annual cash flow from financing activities is $336.60M
What is Mirum Pharmaceuticals annual CFF year-on-year change?
Over the past year, MIRM annual cash flow from financing activities has changed by -$318.90M (-94.74%)
What is Mirum Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of MIRM is $6.36M
What is the all time high quarterly CFF for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high quarterly cash flow from financing activities is $207.13M
What is Mirum Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, MIRM quarterly cash flow from financing activities has changed by +$5.15M (+427.72%)
What is Mirum Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of MIRM is $22.85M
What is the all time high TTM CFF for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high TTM cash flow from financing activities is $336.60M
What is Mirum Pharmaceuticals TTM CFF year-on-year change?
Over the past year, MIRM TTM cash flow from financing activities has changed by -$301.96M (-92.96%)